Literature DB >> 21646486

Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia.

Joanne L Platell1, Rowland N Cobbold, James R Johnson, Anke Heisig, Peter Heisig, Connie Clabots, Michael A Kuskowski, Darren J Trott.   

Abstract

Escherichia coli sequence type 131 (ST131), an emergent multidrug-resistant extraintestinal pathogen, has spread epidemically among humans and was recently isolated from companion animals. To assess for human-companion animal commonality among ST131 isolates, 214 fluoroquinolone-resistant extraintestinal E. coli isolates (205 from humans, 9 from companion animals) from diagnostic laboratories in Australia, provisionally identified as ST131 by PCR, selectively underwent PCR-based O typing and bla(CTX-M-15) detection. A subset then underwent multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE) analysis, extended virulence genotyping, antimicrobial susceptibility testing, and fluoroquinolone resistance genotyping. All isolates were O25b positive, except for two O16 isolates and one O157 isolate, which (along with six O25b-positive isolates) were confirmed by MLST to be ST131. Only 12% of isolates (25 human, 1 canine) exhibited bla(CTX-M-15). PFGE analysis of 20 randomly selected human and all 9 companion animal isolates showed multiple instances of ≥94% profile similarity across host species; 12 isolates (6 human, 6 companion animal) represented pulsotype 968, the most prevalent ST131 pulsotype in North America (representing 23% of a large ST131 reference collection). Virulence gene and antimicrobial resistance profiles differed minimally, without host species specificity. The analyzed ST131 isolates also exhibited a conserved, host species-independent pattern of chromosomal fluoroquinolone resistance mutations. However, eight (89%) companion animal isolates, versus two (10%) human isolates, possessed the plasmid-borne qnrB gene (P < 0.001). This extensive across-species strain commonality, plus the similarities between Australian and non-Australian ST131 isolates, suggest that ST131 isolates are exchanged between humans and companion animals both within Australia and intercontinentally.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21646486      PMCID: PMC3147636          DOI: 10.1128/AAC.00306-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  50 in total

1.  Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.

Authors:  Constança Pomba; Joana Diniz da Fonseca; Bruno Coelho Baptista; José Duarte Correia; Luis Martínez-Martínez
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

2.  Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.

Authors:  Zeki Yumuk; Gokhan Afacan; Marie-Hélène Nicolas-Chanoine; Albert Sotto; Jean-Philippe Lavigne
Journal:  J Antimicrob Chemother       Date:  2008-05-02       Impact factor: 5.790

3.  Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases.

Authors:  G Ll Jones; R E Warren; S J Skidmore; V A Davies; T Gibreel; M Upton
Journal:  J Antimicrob Chemother       Date:  2008-09-30       Impact factor: 5.790

4.  Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.

Authors:  Miguel Blanco; Maria Pilar Alonso; Marie-Hélène Nicolas-Chanoine; Ghizlane Dahbi; Azucena Mora; Jesús E Blanco; Cecilia López; Pilar Cortés; Montserrat Llagostera; Véronique Leflon-Guibout; Beatriz Puentes; Rosalía Mamani; Alexandra Herrera; María Amparo Coira; Fernando García-Garrote; Julia María Pita; Jorge Blanco
Journal:  J Antimicrob Chemother       Date:  2009-04-07       Impact factor: 5.790

5.  Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.

Authors:  Marie-Hélène Nicolas-Chanoine; Jorge Blanco; Véronique Leflon-Guibout; Raphael Demarty; Maria Pilar Alonso; Maria Manuela Caniça; Yeon-Joon Park; Jean-Philippe Lavigne; Johann Pitout; James R Johnson
Journal:  J Antimicrob Chemother       Date:  2007-12-11       Impact factor: 5.790

6.  Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats.

Authors:  James R Johnson; Brian Johnston; Connie R Clabots; Michael A Kuskowski; Elisabeth Roberts; Chitrita DebRoy
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

7.  Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewater.

Authors:  Montserrat Sabaté; Guillem Prats; Eva Moreno; Elisenda Ballesté; Anicet R Blanch; Antonia Andreu
Journal:  Res Microbiol       Date:  2008-03-07       Impact factor: 3.992

8.  Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection.

Authors:  James R Johnson; Michael A Kuskowski; Krista Owens; Connie Clabots; Randall S Singer
Journal:  Vet Microbiol       Date:  2008-10-15       Impact factor: 3.293

9.  Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.

Authors:  Johann D D Pitout; Lorraine Campbell; Deirdre L Church; Daniel B Gregson; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

10.  UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone.

Authors:  Siu Ha Lau; Mary E Kaufmann; David M Livermore; Neil Woodford; Geraldine A Willshaw; Tom Cheasty; Katie Stamper; Suganya Reddy; John Cheesbrough; Frederick J Bolton; Andrew J Fox; Mathew Upton
Journal:  J Antimicrob Chemother       Date:  2008-09-08       Impact factor: 5.790

View more
  36 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.

Authors:  James R Johnson; Olivier Clermont; Brian Johnston; Connie Clabots; Veronika Tchesnokova; Evgeni Sokurenko; Adam F Junka; Beata Maczynska; Erick Denamur
Journal:  J Clin Microbiol       Date:  2014-02-05       Impact factor: 5.948

3.  Antimicrobial resistance trends among canine Escherichia coli isolates obtained from clinical samples in the northeastern USA, 2004-2011.

Authors:  Kevin J Cummings; Victor A Aprea; Craig Altier
Journal:  Can Vet J       Date:  2015-04       Impact factor: 1.008

4.  Large Fecal Reservoir of Escherichia coli Sequence Type 131-H30 Subclone Strains That Are Shared Within Households and Resemble Clinical ST131-H30 Isolates.

Authors:  Muhanad Mohamed; Connie Clabots; Stephen B Porter; Tricia Bender; Paul Thuras; James R Johnson
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

5.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

6.  First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.

Authors:  Mohammad Hasan Namaei; Masoud Yousefi; Masoud Ziaee; Alireza Salehabadi; Malaknaz Ghannadkafi; Elham Amini; Parvin Askari
Journal:  Microb Drug Resist       Date:  2017-02-16       Impact factor: 3.431

Review 7.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  Escherichia coli ST131: variations on a theme of clonal expansion.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Enferm Infecc Microbiol Clin       Date:  2013-03-06       Impact factor: 1.731

9.  Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.

Authors:  James R Johnson; Veronika Tchesnokova; Brian Johnston; Connie Clabots; Pacita L Roberts; Mariya Billig; Kim Riddell; Peggy Rogers; Xuan Qin; Susan Butler-Wu; Lance B Price; Maliha Aziz; Marie-Hélène Nicolas-Chanoine; Chitrita Debroy; Ari Robicsek; Glen Hansen; Carl Urban; Joanne Platell; Darren J Trott; George Zhanel; Scott J Weissman; Brad T Cookson; Ferric C Fang; Ajit P Limaye; Delia Scholes; Sujay Chattopadhyay; David C Hooper; Evgeni V Sokurenko
Journal:  J Infect Dis       Date:  2013-01-03       Impact factor: 5.226

10.  Oxygen-Free Condition Inhibited Biofilm Formation in Extraintestinal Pathogenic Escherichia coli Strain PPECC42 Through Preventing Curli Production.

Authors:  Xianrong Meng; Liyuan Zhang; Bo Hou; Xueling Liu; Shaowen Li
Journal:  Curr Microbiol       Date:  2016-04-19       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.